 | • レポートコード：TPM-B04542 • 出版社/出版日：Transparency Market Research / 2017年10月 • レポート形態：英文、PDF、170ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、医薬品安全性監視・医薬品安全用ソフトウェアの世界市場について調べ、医薬品安全性監視・医薬品安全用ソフトウェアの世界規模、市場動向、市場環境、ソフトウェア別分析、最終用途別分析、展開形態別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・医薬品安全性監視・医薬品安全用ソフトウェアの世界市場動向 ・医薬品安全性監視・医薬品安全用ソフトウェアの世界市場環境 ・医薬品安全性監視・医薬品安全用ソフトウェアの世界市場規模 ・医薬品安全性監視・医薬品安全用ソフトウェアの世界市場規模：ソフトウェア別 ・医薬品安全性監視・医薬品安全用ソフトウェアの世界市場規模：最終用途別 ・医薬品安全性監視・医薬品安全用ソフトウェアの世界市場規模：展開形態別 ・医薬品安全性監視・医薬品安全用ソフトウェアの世界市場：地域別市場規模・分析 ・医薬品安全性監視・医薬品安全用ソフトウェアの北米市場規模・予測 ・医薬品安全性監視・医薬品安全用ソフトウェアのアメリカ市場規模・予測 ・医薬品安全性監視・医薬品安全用ソフトウェアの中南米市場規模・予測 ・医薬品安全性監視・医薬品安全用ソフトウェアのヨーロッパ市場規模・予測 ・医薬品安全性監視・医薬品安全用ソフトウェアのアジア市場規模・予測 ・医薬品安全性監視・医薬品安全用ソフトウェアの日本市場規模・予測 ・医薬品安全性監視・医薬品安全用ソフトウェアの中国市場規模・予測 ・医薬品安全性監視・医薬品安全用ソフトウェアのインド市場規模・予測 ・医薬品安全性監視・医薬品安全用ソフトウェアのアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Pharmacovigilance and Drug Safety Software Market: Overview
The global pharmacovigilance and drug safety software market is envisioned to attract benefits while riding on the ability of products to avert, evaluate, and uncover enduring and temporary side effects of certain medications. Pharmacovigilance software could help to inhibit unnecessary future events and determine the cause of withdrawal. These software could be of great use to all those concerned with the medical process, such as drug consumers, prescribers, and manufacturers. Companies are prominently enabled to put into practice proactive safety surveillance programs with the support provided by pharmacovigilance software as they push new limits in the market.
Global Pharmacovigilance and Drug Safety Software Market: Dynamics
The world pharmacovigilance and drug safety software market is expected to embrace favorable opportunities on the back of government policies related to drug safety regulations and rising rates of cases that pertain to adverse drug reaction. The market could also gain impetus from the surging need for new drug development, considering the high prevalence of chronic ailments and growing geriatric population. Pharmacovigilance software could find an application to minimize the limitations faced by small organizations relating to personnel and financial resources.
More prospects are projected to take birth in the world pharmacovigilance and drug safety software market with mounting private and public investments in pharmaceutical research and development activities. The high growth rate of pharmaceutical companies conducting research outsourcing could augur well for the rise in the demand for pharmacovigilance and drug safety software.
Global Pharmacovigilance and Drug Safety Software Market: Segmentation
The international pharmacovigilance and drug safety software market is predicted to be classified into adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software as per segmentation by type of software. With a 39.7% share achieved in 2017, adverse event reporting software could rake in a greater revenue in the market by the end of 2022.
In terms of end user, the international pharmacovigilance and drug safety software market is predicted to be segregated into pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other pharmacovigilance service providers.
On the basis of delivery mode, there could be prospects birthing in the international pharmacovigilance and drug safety software market from vital segments such as on-premise delivery mode and cloud-based delivery mode.
In respect of regional segmentation, the international pharmacovigilance and drug safety software market is anticipated to be divided into Latin America, the Middle East and Africa (MEA), North America, Asia Pacific except Japan (APEJ), and Europe. Among key countries, Japan could expand at a slightly better CAGR of 3.9% than that of the MEA. However, North America is prognosticated to lead the market after earning a US$58.5 mn in 2017.
Global Pharmacovigilance and Drug Safety Software Market: Competition
The worldwide pharmacovigilance and drug safety software market is envisaged to witness the presence of significant companies such as UMBRA Global LLC, AB Cube, United BioSource Corporation, Sparta Systems, Inc., Oracle Corporation, EXTEDO GmbH, Ennov Solutions, Inc., and ArisGlobal.
レポート目次1. Global Pharmacovigilance and Drug Safety Software Market – Executive Summary
2. Global Pharmacovigilance and Drug Safety Software Market Overview
2.1. Introduction
2.1.1. Global Pharmacovigilance and Drug Safety Software Market Taxonomy
2.1.2. Global Pharmacovigilance and Drug Safety Software Market Definition
2.2. Global Pharmacovigilance and Drug Safety Software Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Pharmacovigilance and Drug Safety Software Market Y-o-Y Growth
2.3. Global Pharmacovigilance and Drug Safety Software Market Dynamics
2.4. Supply Chain
2.5. Cost Structure
2.6. Pricing Analysis
2.7. Technological Advancement
2.8. List of Distributors
2.9. Key Participants Market Presence (Intensity Map) By Region
3. Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast By Software Type
3.1. Global Pharmacovigilance and Drug Safety Software Market Size and Forecast By Software Type, 2012-2022
3.1.1. Adverse Event Reporting Software Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Drug Safety Audits Software Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
3.1.3. Issue Tracking Software Market Size and Forecast, 2012-2022
3.1.3.1. Revenue (US$ Mn) Comparison, By Region
3.1.3.2. Market Share Comparison, By Region
3.1.3.3. Y-o-Y growth Comparison, By Region
3.1.4. Fully Integrated Software Market Size and Forecast, 2012-2022
3.1.4.1. Revenue (US$ Mn) Comparison, By Region
3.1.4.2. Market Share Comparison, By Region
3.1.4.3. Y-o-Y growth Comparison, By Region
4. Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast By End User
4.1. Global Pharmacovigilance and Drug Safety Software Market Size and Forecast By End User, 2012-2022
4.1.1. Pharma and Biotech Companies Market Size and Forecast, 2012-2022
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Contract Research Organizations (CROs) Market Size and Forecast, 2012-2022
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Business Process Outsourcing (BPO) Firms Market Size and Forecast, 2012-2022
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Other Pharmacovigilance Service Providers Market Size and Forecast, 2012-2022
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
5. Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast By Delivery Mode
5.1. Global Pharmacovigilance and Drug Safety Software Market Size and Forecast By Delivery Mode, 2012-2022
5.1.1. On-premise Delivery Mode Market Size and Forecast, 2012-2022
5.1.1.1. Revenue (US$ Mn) Comparison, By Region
5.1.1.2. Market Share Comparison, By Region
5.1.1.3. Y-o-Y growth Comparison, By Region
5.1.2. Cloud-based Delivery Mode Market Size and Forecast, 2012-2022
5.1.2.1. Revenue (US$ Mn) Comparison, By Region
5.1.2.2. Market Share Comparison, By Region
5.1.2.3. Y-o-Y growth Comparison, By Region
6. Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast By Region
6.1. Global Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
6.1.1. North America Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
6.1.1.1. Revenue (US$ Mn) Comparison, By Software Type
6.1.1.2. Revenue (US$ Mn) Comparison, By End User
6.1.1.3. Revenue (US$ Mn) Comparison, By Delivery Mode
6.1.2. Latin America Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
6.1.2.1. Revenue (US$ Mn) Comparison, By Software Type
6.1.2.2. Revenue (US$ Mn) Comparison, By End User
6.1.2.3. Revenue (US$ Mn) Comparison, By Delivery Mode
6.1.3. Europe Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
6.1.3.1. Revenue (US$ Mn) Comparison, By Software Type
6.1.3.2. Revenue (US$ Mn) Comparison, By End User
6.1.3.3. Revenue (US$ Mn) Comparison, By Delivery Mode
6.1.4. Japan Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
6.1.4.1. Revenue (US$ Mn) Comparison, By Software Type
6.1.4.2. Revenue (US$ Mn) Comparison, By End User
6.1.4.3. Revenue (US$ Mn) Comparison, By Delivery Mode
6.1.5. APEJ Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
6.1.5.1. Revenue (US$ Mn) Comparison, By Software Type
6.1.5.2. Revenue (US$ Mn) Comparison, By End User
6.1.5.3. Revenue (US$ Mn) Comparison, By Delivery Mode
6.1.6. MEA Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
6.1.6.1. Revenue (US$ Mn) Comparison, By Software Type
6.1.6.2. Revenue (US$ Mn) Comparison, By End User
6.1.6.3. Revenue (US$ Mn) Comparison, By Delivery Mode
7. North America Pharmacovigilance and Drug Safety Software Market Analysis and Forecast, By Country, 2012-2022
7.1. US Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
7.1.1. Revenue (US$ Mn) Comparison, By Software Type
7.1.2. Revenue (US$ Mn) Comparison, By End User
7.1.3. Revenue (US$ Mn) Comparison, By Delivery Mode
7.2. Canada Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
7.2.1. Revenue (US$ Mn) Comparison, By Software Type
7.2.2. Revenue (US$ Mn) Comparison, By End User
7.2.3. Revenue (US$ Mn) Comparison, By Delivery Mode
8. Latin America Pharmacovigilance and Drug Safety Software Market Analysis and Forecast, By Country, 2012-2022
8.1. Brazil Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
8.1.1. Revenue (US$ Mn) Comparison, By Software Type
8.1.2. Revenue (US$ Mn) Comparison, By End User
8.1.3. Revenue (US$ Mn) Comparison, By Delivery Mode
8.2. Mexico Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
8.2.1. Revenue (US$ Mn) Comparison, By Software Type
8.2.2. Revenue (US$ Mn) Comparison, By End User
8.2.3. Revenue (US$ Mn) Comparison, By Delivery Mode
8.3. Argentina Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
8.3.1. Revenue (US$ Mn) Comparison, By Software Type
8.3.2. Revenue (US$ Mn) Comparison, By End User
8.3.3. Revenue (US$ Mn) Comparison, By Delivery Mode
9. Europe Pharmacovigilance and Drug Safety Software Market Analysis and Forecast, By Country, 2012-2022
9.1. Germany Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
9.1.1. Revenue (US$ Mn) Comparison, By Software Type
9.1.2. Revenue (US$ Mn) Comparison, By End User
9.1.3. Revenue (US$ Mn) Comparison, By Delivery Mode
9.2. UK Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
9.2.1. Revenue (US$ Mn) Comparison, By Software Type
9.2.2. Revenue (US$ Mn) Comparison, By End User
9.2.3. Revenue (US$ Mn) Comparison, By Delivery Mode
9.3. France Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
9.3.1. Revenue (US$ Mn) Comparison, By Software Type
9.3.2. Revenue (US$ Mn) Comparison, By End User
9.3.3. Revenue (US$ Mn) Comparison, By Delivery Mode
9.4. Spain Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
9.4.1. Revenue (US$ Mn) Comparison, By Software Type
9.4.2. Revenue (US$ Mn) Comparison, By End User
9.4.3. Revenue (US$ Mn) Comparison, By Delivery Mode
9.5. Italy Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
9.5.1. Revenue (US$ Mn) Comparison, By Software Type
9.5.2. Revenue (US$ Mn) Comparison, By End User
9.5.3. Revenue (US$ Mn) Comparison, By Delivery Mode
9.6. Nordic Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
9.6.1. Revenue (US$ Mn) Comparison, By Software Type
9.6.2. Revenue (US$ Mn) Comparison, By End User
9.6.3. Revenue (US$ Mn) Comparison, By Delivery Mode
10. Japan Pharmacovigilance and Drug Safety Software Market Analysis and Forecast, By Country, 2012-2022
10.1. Japan Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
10.1.1. Revenue (US$ Mn) Comparison, By Software Type
10.1.2. Revenue (US$ Mn) Comparison, By End User
10.1.3. Revenue (US$ Mn) Comparison, By Delivery Mode
11. APEJ Pharmacovigilance and Drug Safety Software Market Analysis and Forecast, By Country, 2012-2022
11.1. China Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
11.1.1. Revenue (US$ Mn) Comparison, By Software Type
11.1.2. Revenue (US$ Mn) Comparison, By End User
11.1.3. Revenue (US$ Mn) Comparison, By Delivery Mode
11.2. India Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
11.2.1. Revenue (US$ Mn) Comparison, By Software Type
11.2.2. Revenue (US$ Mn) Comparison, By End User
11.2.3. Revenue (US$ Mn) Comparison, By Delivery Mode
11.3. Malaysia Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
11.3.1. Revenue (US$ Mn) Comparison, By Software Type
11.3.2. Revenue (US$ Mn) Comparison, By End User
11.3.3. Revenue (US$ Mn) Comparison, By Delivery Mode
11.4. Thailand Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
11.4.1. Revenue (US$ Mn) Comparison, By Software Type
11.4.2. Revenue (US$ Mn) Comparison, By End User
11.4.3. Revenue (US$ Mn) Comparison, By Delivery Mode
11.5. Singapore Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
11.5.1. Revenue (US$ Mn) Comparison, By Software Type
11.5.2. Revenue (US$ Mn) Comparison, By End User
11.5.3. Revenue (US$ Mn) Comparison, By Delivery Mode
11.6. Australia Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
11.6.1. Revenue (US$ Mn) Comparison, By Software Type
11.6.2. Revenue (US$ Mn) Comparison, By End User
11.6.3. Revenue (US$ Mn) Comparison, By Delivery Mode
12. MEA Pharmacovigilance and Drug Safety Software Market Analysis and Forecast, By Country, 2012-2022
12.1. GCC Countries Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
12.1.1. Revenue (US$ Mn) Comparison, By Software Type
12.1.2. Revenue (US$ Mn) Comparison, By End User
12.1.3. Revenue (US$ Mn) Comparison, By Delivery Mode
12.2. South Africa Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
12.2.1. Revenue (US$ Mn) Comparison, By Software Type
12.2.2. Revenue (US$ Mn) Comparison, By End User
12.2.3. Revenue (US$ Mn) Comparison, By Delivery Mode
12.3. Nigeria Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
12.3.1. Revenue (US$ Mn) Comparison, By Software Type
12.3.2. Revenue (US$ Mn) Comparison, By End User
12.3.3. Revenue (US$ Mn) Comparison, By Delivery Mode
12.4. Israel Pharmacovigilance and Drug Safety Software Market Size and Forecast, 2012-2022
12.4.1. Revenue (US$ Mn) Comparison, By Software Type
12.4.2. Revenue (US$ Mn) Comparison, By End User
12.4.3. Revenue (US$ Mn) Comparison, By Delivery Mode
13. Global Pharmacovigilance and Drug Safety Software Market Company Share, Competition Landscape and Company Profiles
13.1. Company Share Analysis
13.2. Competition Landscape
13.3. Company Profiles
13.3.1. ArisGlobal
13.3.2. Ennov Solutions Inc.
13.3.3. EXTEDO GmbH
13.3.4. Oracle Corporation
13.3.5. Sparta Systems, Inc.
13.3.6. United BioSource Corporation
13.3.7. AB Cube
13.3.8. UMBRA Global LLC
14. Research Methodology
15. Secondary and Primary Sources
16. Assumptions and Acronyms
17. Disclaimer
List of TablesTABLE 1 Global Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), 2012-2016
TABLE 2 Global Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), 2017-2022
TABLE 3 Global Pharmacovigilance and Drug Safety Software Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global Adverse Event Reporting Software Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global Adverse Event Reporting Software Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global Adverse Event Reporting Software Segment Market Share, By Region 2012-2016
TABLE 7 Global Adverse Event Reporting Software Segment Market Share, By Region 2017-2022
TABLE 8 Global Adverse Event Reporting Software Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global Drug Safety Audits Software Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global Drug Safety Audits Software Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global Drug Safety Audits Software Segment Market Share, By Region 2012-2016
TABLE 12 Global Drug Safety Audits Software Segment Market Share, By Region 2017-2022
TABLE 13 Global Drug Safety Audits Software Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global Issue Tracking Software Segment Value (US$ Mn), By Region 2012-2016
TABLE 15 Global Issue Tracking Software Segment Value (US$ Mn), By Region 2017-2022
TABLE 16 Global Issue Tracking Software Segment Market Share, By Region 2012-2016
TABLE 17 Global Issue Tracking Software Segment Market Share, By Region 2017-2022
TABLE 18 Global Issue Tracking Software Segment Y-o-Y, By Region 2015-2022
TABLE 19 Global Fully Integrated Software Segment Value (US$ Mn), By Region 2012-2016
TABLE 20 Global Fully Integrated Software Segment Value (US$ Mn), By Region 2017-2022
TABLE 21 Global Fully Integrated Software Segment Market Share, By Region 2012-2016
TABLE 22 Global Fully Integrated Software Segment Market Share, By Region 2017-2022
TABLE 23 Global Fully Integrated Software Segment Y-o-Y, By Region 2015-2022
TABLE 24 Global Pharma and Biotech Companies Segment Value (US$ Mn), By Region 2012-2016
TABLE 25 Global Pharma and Biotech Companies Segment Value (US$ Mn), By Region 2017-2022
TABLE 26 Global Pharma and Biotech Companies Segment Market Share, By Region 2012-2016
TABLE 27 Global Pharma and Biotech Companies Segment Market Share, By Region 2017-2022
TABLE 28 Global Pharma and Biotech Companies Segment Y-o-Y, By Region 2015-2022
TABLE 29 Global Contract Research Organizations (CROs) Segment Value (US$ Mn), By Region 2012-2016
TABLE 30 Global Contract Research Organizations (CROs) Segment Value (US$ Mn), By Region 2017-2022
TABLE 31 Global Contract Research Organizations (CROs) Segment Market Share, By Region 2012-2016
TABLE 32 Global Contract Research Organizations (CROs) Segment Market Share, By Region 2017-2022
TABLE 33 Global Contract Research Organizations (CROs) Segment Y-o-Y, By Region 2015-2022
TABLE 34 Global Business Process Outsourcing (BPO) Firms Segment Value (US$ Mn), By Region 2012-2016
TABLE 35 Global Business Process Outsourcing (BPO) Firms Segment Value (US$ Mn), By Region 2017-2022
TABLE 36 Global Business Process Outsourcing (BPO) Firms Segment Market Share, By Region 2012-2016
TABLE 37 Global Business Process Outsourcing (BPO) Firms Segment Market Share, By Region 2017-2022
TABLE 38 Global Business Process Outsourcing (BPO) Firms Segment Y-o-Y, By Region 2015-2022
TABLE 39 Global Other Pharmacovigilance Service Providers Segment Value (US$ Mn), By Region 2012-2016
TABLE 40 Global Other Pharmacovigilance Service Providers Segment Value (US$ Mn), By Region 2017-2022
TABLE 41 Global Other Pharmacovigilance Service Providers Segment Market Share, By Region 2012-2016
TABLE 42 Global Other Pharmacovigilance Service Providers Segment Market Share, By Region 2017-2022
TABLE 43 Global Other Pharmacovigilance Service Providers Segment Y-o-Y, By Region 2015-2022
TABLE 44 Global On-premise Delivery Mode Segment Value (US$ Mn), By Region 2012-2016
TABLE 45 Global On-premise Delivery Mode Segment Value (US$ Mn), By Region 2017-2022
TABLE 46 Global On-premise Delivery Mode Segment Market Share, By Region 2012-2016
TABLE 47 Global On-premise Delivery Mode Segment Market Share, By Region 2017-2022
TABLE 48 Global On-premise Delivery Mode Segment Y-o-Y, By Region 2015-2022
TABLE 49 Global Cloud-based Delivery Mode Segment Value (US$ Mn), By Region 2012-2016
TABLE 50 Global Cloud-based Delivery Mode Segment Value (US$ Mn), By Region 2017-2022
TABLE 51 Global Cloud-based Delivery Mode Segment Market Share, By Region 2012-2016
TABLE 52 Global Cloud-based Delivery Mode Segment Market Share, By Region 2017-2022
TABLE 53 Global Cloud-based Delivery Mode Segment Y-o-Y, By Region 2015-2022
TABLE 54 North America Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 55 North America Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 56 North America Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 57 North America Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 58 North America Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 59 North America Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 60 Latin America Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 61 Latin America Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 62 Latin America Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 63 Latin America Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 64 Latin America Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 65 Latin America Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 66 Europe Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 67 Europe Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 68 Europe Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 69 Europe Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 70 Europe Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 71 Europe Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 72 Japan Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 73 Japan Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 74 Japan Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 75 Japan Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 76 Japan Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 77 Japan Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 78 APEJ Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 79 APEJ Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 80 APEJ Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 81 APEJ Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 82 APEJ Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 83 APEJ Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 84 MEA Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 85 MEA Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 86 MEA Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 87 MEA Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 88 MEA Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 89 MEA Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 90 US Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 91 US Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 92 US Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 93 US Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 94 US Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 95 US Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 96 Canada Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 97 Canada Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 98 Canada Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 99 Canada Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 100 Canada Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 101 Canada Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 102 Brazil Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 103 Brazil Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 104 Brazil Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 105 Brazil Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 106 Brazil Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 107 Brazil Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 108 Mexico Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 109 Mexico Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 110 Mexico Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 111 Mexico Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 112 Mexico Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 113 Mexico Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 114 Argentina Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 115 Argentina Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 116 Argentina Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 117 Argentina Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 118 Argentina Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 119 Argentina Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 120 Germany Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 121 Germany Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 122 Germany Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 123 Germany Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 124 Germany Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 125 Germany Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 126 UK Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 127 UK Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 128 UK Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 129 UK Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 130 UK Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 131 UK Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 132 France Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 133 France Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 134 France Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 135 France Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 136 France Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 137 France Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 138 Spain Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 139 Spain Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 140 Spain Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 141 Spain Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 142 Spain Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 143 Spain Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 144 Italy Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 145 Italy Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 146 Italy Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 147 Italy Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 148 Italy Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 149 Italy Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 150 Nordic Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 151 Nordic Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 152 Nordic Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 153 Nordic Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 154 Nordic Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 155 Nordic Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 156 Japan Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 157 Japan Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 158 Japan Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 159 Japan Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 160 Japan Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 161 Japan Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 162 China Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 163 China Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 164 China Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 165 China Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 166 China Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 167 China Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 168 India Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 169 India Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 170 India Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 171 India Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 172 India Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 173 India Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 174 Malaysia Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 175 Malaysia Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 176 Malaysia Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 177 Malaysia Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 178 Malaysia Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 179 Malaysia Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 180 Thailand Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 181 Thailand Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 182 Thailand Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 183 Thailand Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 184 Thailand Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 185 Thailand Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 186 Singapore Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 187 Singapore Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 188 Singapore Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 189 Singapore Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 190 Singapore Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 191 Singapore Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 192 Australia Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 193 Australia Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 194 Australia Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 195 Australia Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 196 Australia Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 197 Australia Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 198 GCC Countries Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 199 GCC Countries Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 200 GCC Countries Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 201 GCC Countries Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 202 GCC Countries Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 203 GCC Countries Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 204 South Africa Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 205 South Africa Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 206 South Africa Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 207 South Africa Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 208 South Africa Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 209 South Africa Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 210 Nigeria Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 211 Nigeria Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 212 Nigeria Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 213 Nigeria Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 214 Nigeria Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 215 Nigeria Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022
TABLE 216 Israel Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2012-2016
TABLE 217 Israel Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Software Type 2017-2022
TABLE 218 Israel Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2012-2016
TABLE 219 Israel Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By End User 2017-2022
TABLE 220 Israel Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2012-2016
TABLE 221 Israel Pharmacovigilance and Drug Safety Software Market Value (US$ Mn), By Delivery Mode 2017-2022